Elevated expression of TGF-β3 has been associated with poor prognosis in bladder cancer [8], while TGF-β1 has been implicated in tumor progression and adverse outcomes across multiple cancer types [9]. The gene discussed is TGFB1; the disease is urinary bladder cancer.